Clinical Trial Update: Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating Velcade (bortezomib) plus melphalan and prednisone in older untreated multiple myeloma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Velcade (bortezomib)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED